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RESEARCH ARTICLE
Characterization of themammalian family of DCN-type NEDD8E3
ligases
Matthew J. Keuss‡, Yann Thomas‡, Robin Mcarthur, Nicola T. Wood, Axel Knebel and Thimo Kurz*,§
ABSTRACT
Cullin-RING ligases (CRL) are ubiquitin E3 enzymes that bind
substrates through variable substrate receptor proteins and are
activated by attachment of the ubiquitin-like protein NEDD8 to the
cullin subunit. DCNs are NEDD8 E3 ligases that promote neddylation.
Mammalian cells express five DCN-like (DCNL) proteins but little is
known about their specific functions or interaction partners. We found
that DCNLs form stable stoichiometric complexes with CAND1 and
cullins that can only be neddylated in the presence of a substrate
adaptor. These CAND–cullin–DCNL complexes might represent
‘reserve’ CRLs that can be rapidly activated when needed. We further
found that all DCNLs interactwithmost cullin subtypes, but that theyare
probably responsible for the neddylation of different subpopulations of
any given cullin. This is consistent with the fact that the subcellular
localization of DCNLs in tissue culture cells differs and that they show
unique tissue-specific expression patterns inmice. Thus, the specificity
between DCNL-type NEDD8 E3 enzymes and their cullin substrates is
only apparent in well-defined physiological contexts and related to their
subcellular distribution and restricted expression.
KEY WORDS: Ubiquitin, NEDD8, Cullin-RING ligases, CRL, SCCRO,
DCUN1D
INTRODUCTION
Ubiquitin is a small (8 kDa) signaling protein that regulates most
cellular activities. The majority of ubiquitin’s functions require its
linkage to other proteins through isopeptide bonds. This is mediated
by the sequential action of three enzyme families, termed E1, E2 and
E3 (Hershko and Ciechanover, 1998). E3 enzymes are much more
numerous (∼600 proteins) than E1 (2 proteins) and E2 enzymes
(∼40 proteins), reflecting their role as substrate specificity factors of
the reaction (Hershko and Ciechanover, 1998). By far the largest
class of E3 enzymes is formed by the cullin-RING ligase (CRL)
family. These are modular E3s built around a heterodimeric catalytic
scaffolding complex that consists of a small RING-finger protein
(either RBX1 or RBX2) bound to the C-terminus of a cullin protein.
The N-terminus of cullin proteins can interact with many different
substrate-specificity modules that recruit substrates, whereas the
RING finger protein interacts with ubiquitin-charged E2 enzymes
(Petroski andDeshaies, 2005). Mammalian cells contain eight cullin
proteins, Cul1, Cul2, Cul3, Cul4A, Cul4B, Cul5, Cul7 and Cul9/
Parc8 (Sarikas et al., 2011) and although only a limited number of
CRL complexes have assigned substrates, it is estimated that ∼300
CRL complexes exist in humans (Enchev et al., 2015).
The assembly and activity of CRLs is regulated through reversible
conjugation of NEDD8, a ubiquitin-like protein, to a conserved
lysine residue in the cullin backbone (Lammer et al., 1998;
Liakopoulos et al., 1998; Pintard et al., 2003; Lyapina et al., 2001;
Bornstein et al., 2006; Cope et al., 2002). NEDD8 modification
activates CRLs by inducing structural flexibility of the cullin C-
terminus, allowing RBX1 and RBX2 to adopt productive
conformations for the transfer of ubiquitin onto substrates (Duda
et al., 2008). Neddylation and de-neddylation of cullins are also
important to regulate CRL composition, as only de-neddylated
complexes can interact with the exchange factor CAND1 that
regulates the release of old and the association of new substrate
adaptors to cullin–RING core complexes (Goldenberg et al., 2004;
Liu et al., 2002; Zemla et al., 2013; Zheng et al., 2002; Pierce et al.,
2013; Wu et al., 2013). Like ubiquitin, NEDD8 becomes conjugated
to its cullin substrates by E1, E2 and E3 enzymes (Kurz et al., 2005;
Rabut and Peter, 2008; Rabut et al., 2011). The single E1 NEDD8-
activating enzyme (NAE) is a heterodimer of two proteins, APP-BP1
(also known as NAE1 and ULA1) and UBA3 (Walden et al., 2003).
Two NEDD8-conjugating E2 enzymes are encoded by UBE2M and
UBE2F (Huang et al., 2009). In addition to being ubiquitin E3s,
RBX1 andRBX2 are also NEDD8E3s that transfer NEDD8 onto the
cullins they are bound to, but they require auxiliary E3 factors to
direct NEDD8 towards the right lysine residue (Scott et al., 2010).
These factors are encoded by proteins of the DCN1 (defective in
cullin neddylation 1) family. In lower organisms, single DCN1
homologs exist that promote the neddylation of all cullins (Kurz et al.,
2005, 2008), whereas multiple DCN1 molecules are encoded by the
genomes of higherorganisms.Human cells, for example, express five
DCN1-like proteins termed DCNL1–DCNL5 (also named
DCUN1D1–5 for defective in cullin neddylation 1 domain-
containing protein 1–5 or SCCRO1-5) (Bommelje et al., 2014;
Sarkaria et al., 2006; Meyer-Schaller et al., 2009; Kim et al., 2008;
Huang et al., 2014). TheseDCNLs have distinctN-terminal domains,
but share a conserved C-terminal potentiating neddylation (PONY)
domain. The PONY domain directly binds to cullins through
invariant residues, called the DAD patch (D226, A253, D259 in
Saccharomyces cerevisiae Dcn1), whereas the function of the
variable N-terminal domains are largely unclear (Kurz et al.,
2005). The N-terminus of yeast Dcn1 encodes a ubiquitin-binding
UBA domain, which is also present in the human DCNL1 and
DCNL2 isoforms. Although conserved, the UBA domain is not
required for DCN1s neddylation activity in vitro or in vivo and its
function remains to be determined (Kurz et al., 2008; Wu et al.,
2011). The regulation of DCNL activity in general appears to be
important, as DCNL1 is highly amplified in various tumors where itReceived 9 October 2015; Accepted 14 February 2016
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acts as an oncogene (squamous-cell-carcinoma-related oncogene)
(Broderick et al., 2010; Sarkaria et al., 2006) and DCNL5
(DCUN1D5) was also recently reported to be overexpressed in
some oral and lung squamous cell carcinomas (Bommelje et al.,
2014). Consistent with these observations, inhibition of neddylation
by a small molecule drug (MLN4924) shows promise in clinical trials
for the treatment of hematological malignancies (Soucy et al., 2009).
Whereas DCNL1 and DCNL2 contain N-terminal UBA
domains, DCNL3, DCNL4 and DCNL5 contain unique N-termini
that are predicted to be unstructured. In general, the N-termini are
thought to govern the subcellular localization of DCNs or their
cullin specificity. However, comprehensive evidence in support of
this hypothesis is missing, except for DCNL1 and DCNL3 (Wu
et al., 2011; Meyer-Schaller et al., 2009).
Here we have explored the specificity and interactions of the
different mammalian DCNL homologs. We find that in cells all
DCNLs interact strongly with most cullins and CAND1, a known
regulator of CRLs that is required to exchange substrate adaptors (Liu
et al., 2002; Zheng et al., 2002). We further find that the five
mammalian DCNLs are widely expressed in tissue culture cells, but
differ in their subcellular localization patterns. The expression of
DCNLs in animal tissue ismore restricted, where DCNL1 seems to be
the only broadly expressed DCNL. In tissue culture cells, none of the
DCNLs shows specificity towards a cullin subtype, supporting a
model whereby all or most DCNLs contribute to the overall
neddylation levels of cullins. However, it also suggests that DCNLs
are not simply redundant, but instead neddylate distinct
subpopulations of cullins. One striking example is the non-
redundant contribution of DCNL1 and DCNL5 to the neddylation
of cullin4A.Our findings thus suggest that althoughDCNLs appear to
indiscriminately neddylate cullins, they maintain unique functions
that are not redundant with other DCNLs.
RESULTS
DCNLs interact with cullins and CAND1
Using HEK-293 cell lines stably expressing N-terminally FLAG-
tagged isoforms of each DCNL, we determined their interaction
partners by mass spectrometry after FLAG-immunoprecipitation
(Kurz et al., 2008) (Fig. 1).Using SDS-PAGEgels followedby silver
staining (Fig. 1A,C),we detected unique interaction patterns for each
DCNL, with the exception of one protein at >100 kDa, that was
prominently present in all immunoprecipitates, but too large to be a
cullin. All the specific interactors were lost when theDAD patchwas
mutated, suggesting that the interactions are mediated by cullins.
The mass-spectrometry analyses revealed that most DCNLs
interacted with most cullin subtypes (Cul1, 2, 3, 4A, 4B and 5) with
the exception of Cul7 and Cul9 (Fig. 1B). There was no readily
apparent difference in the binding to the different cullins, except for
DCNL4, which seemed to be overall binding less to Cul3 and did
not bind to Cul4A or Cul4B (Fig. 1B). However, this apparent lack
of interaction was probably a result of the very low expression level
of FLAG–DCNL4 in our cell line compared with the other cell
lines. This resulted in considerably less FLAG–DCNL4 being
immunoprecipitated (Fig. 1C), which might have dropped the
amount of co-precipitated Cul4A and Cul4B below the detection
limit. Nevertheless, from these results we concluded that no DCNL
has a readily apparent cullin preference in cells. This is in
accordance with previously published in vitro data that showed
that purified recombinant DCNLs can bind to all cullins with only
slightly different affinities (Monda et al., 2013). Our results now
suggest that in cells, DCNLs are indeed capable of binding to most,
if not all, cullins indiscriminately. Interestingly, when wewent on to
confirm the identified interactions by western blotting (Fig. 1C) we
found that DCNLs only interacted with non-neddylated cullins,
strongly suggesting that they are released from the cullin complexes
once they are neddylated. Consistent with the low expression levels
of our FLAG–DCNL4 cell line, we were unable to confirm by
western blot the interactions between FLAG–DCNL4 and the
binding partners identified by mass spectrometry.
In the mass spectrometry analysis we found very few additional
proteins outside of cullins that specifically bound to DCNLs.
DCNL1, 2, 3 and 5 also interacted with other regulators or subunits
of cullin-RING ligases such as RBX1, RBX2, elongin B (Cul2
substrate adaptor) and DDB1 (Cul4A substrate adaptor). The only
non-cullin related interactor we identified was the mitochondrial
protein ACADVL that bound to DCNL5. We could not, however,
independently confirm this interaction by western blotting, casting
doubt on the validity of this interaction (Fig. S1).
Most strikingly, we detected a very strong interaction of all
DCNLs with CAND1 (Fig. 1B). This was surprising, as CAND1
only binds to non-neddylated cullins and prevents their neddylation
when bound (Liu et al., 2002; Zheng et al., 2002). Based on peptide
counts, CAND1 was the strongest interactor for all DCNs, and by
size, it fit the large protein that we had readily identified on silver-
stained gels (Fig. 1A). A mutation of the DAD patch on DCNLs
abolished binding to all cullins, but also to CAND1, suggesting that
the interaction is bridged by cullins (Fig. 1C). Indeed, all DCNLs
were able to form stable stoichiometric heterotrimeric complexes
in vitro with recombinantly expressed CAND1 and the cullin
Cul3−Rbx1 (Fig. 2A–E). Formation of the complexes in vitro was
dependent on the presence of Cul3−Rbx1, and we could not detect a
direct interaction between any DCNL and CAND1 (Fig. 2A–E).
Thus, DCNLs can form stable stoichiometric complexes with
cullins and CAND1 that are bridged by the cullin protein.
Given that CAND1–cullin complexes are resistant to neddylation,
we next tested if this was also true for CAND1–Cul3–DCNL
complexes. We could show in vitro that the presence of CAND1
strongly inhibited the neddylation of Cul3–Rbx1 irrespective of the
presence of any DCNL in the complex (Fig. 2F–J). These results
posed the question why such complexes of CAND–cullin–DCNL
would form in the first place. One possibility was that they represent
reservoir cullin complexes that are inactive, but primed for
neddylation and thus rapid activation when needed. As active
complexes need to bind to substrates, we reasoned that the inactive
complexes might become activated in the presence of a substrate
adaptor. Indeed, the addition of stoichiometric amounts of the Cul3
substrate adaptor KLHL3 to the in vitro reaction overcame the
CAND1-dependent inhibition of neddylation (Fig. 2F–J). It is
thus highly plausible that heterotrimeric CAND1–cullin–DCNL
complexes exist in the cell to allow rapid activation by neddylation
as soon as they encounter substrate adaptor complexes.
DCNLs differ in their subcellular localization and expression
profiles
Based on our mass spectrometry results, all DCNLs are able to
interact with most cullins. We thus next tried to understand if they
are fully redundant or also have unique functions. We first
determined their expression profiles in mouse tissue and tissue
culture cells. Using specific antibodies for each family member
(Fig. S2), we found that all DCNLs are well-expressed in the three
tissue culture cell lines we tested (HEK-293, U2OS and HeLa)
(Fig. 3A). DCNL1 and DCNL2 are expressed to similar levels in all
three cell lines. DCNL3 expression is comparatively low, but it is
best expressed in U2OS cells and less abundantly in HeLa and
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HEK-293 cells (Fig. 3A). DCNL4 is predicted to have at least three
splice variants (29 kDa, 34 kDa, 38 kDa), and we can detect at least
two of these isoforms in tissue culture cells to relatively high levels,
but most strongly in HEK-293 cells (Fig. 3A). Strikingly, DCNL5 is
the most strongly expressed DCNL in all cell lines tested, suggesting
that it might have a major role in proliferating cells (Fig. 3A).
This general expression is in stark contrast to DCNL expression
in mouse tissue. Here, DCNL5was the least expressed of all DCNLs
(Fig. 3A). DCNL1, by contrast, was the most widely expressed
isoform and could easily be detected in all tissues (Fig. 3A).
DCNL2, although very similar in sequence to DCNL1, was not
expressed as widely and mostly found in liver and kidney and, as
what seemed to be a highly post-translationally modified form, in
brain (Fig. 3A). Expression of DCNL3 was mostly restricted to
testis and brain. The expression of different DCNL4 isoforms was
morewidely detectable, but most strongly in testis, brain, heart, liver
Fig. 1. Characterization of DCNL interactors. (A) Silver-stained gels of FLAG immunoprecipitations from HEK293 cells stably expressing wild-type (WT) or
cullin-binding-deficient DAD patchmutants of all mammalian DCNLs (DCNL1–5). Asterisks denote FLAG–DCNL proteins. WT, but not DADmutants, specifically
co-immunoprecipitate proteins that are not present in the empty FLAG or control, including a large protein with molecular mass >98 kDa (arrow). (B) Heatmap of
DCNL interactors identified by mass spectrometry of immunoprecipitations in A. Interactors with >3 unique peptides detected are plotted. All DCNLs co-
immunoprecipitate most cullins, as well as cullin-associated proteins RBX1, RBX2 (RNF7), the Cul4A adaptor protein DDB1 and the Cul2/5 adaptor elongin B
(TCEB1). The strongest interactor of all DCNLs is CAND1, the CRL substrate adaptor exchange factor. (C) Immunoprecipitation of FLAG–DCNL1, 2, 3 and 4 (top
panels) and FLAG-DCNL5 (bottom panels) from stably expressing HEK293 cells followed by western blot analysis. The slower migrating of the two cullin-reactive
bands is the neddylated form (asterisk). Only WT DCNLs co-immunoprecipitate mostly non-neddylated cullins, CAND1 and RBX1. Expression levels of FLAG–
DCNL4 were too low in this experiment to detect co-immunoprecipitating proteins.
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Fig. 2. DCNLs forms a stable complex with cullin and CAND1. (A–E) His6–DCNL1, 2, 3, 4 and 5 were bound to magnetic Ni-NTA beads, incubated for 20 min
at 4°C with CAND1 or Cul3–CAND1 complexes and washed with 10 mM imidazole to reduce nonspecific binding. Bound proteins were eluted with 300 mM
imidazole and separated by SDS-PAGE followed by Coomassie staining. CAND1, Cul3 and DCNLs form a stoichiometric complex (lane 7) and CAND1 does not
bind to any His6–DCNL in the absence of Cul3 (lane 6). (F–J) In vitro neddylation reactions of Cul3 show inhibition by CAND1 and rescue with substrate adaptor
KLHL3. Each reaction contained 1 µM Cul3 and 1 µM DCNL and as indicated 1 µM CAND1, 1 µM KLHL3 (1×), or 10 µM KLHL3 (10×). Neddylation was induced
by addition to a final concentration of 34 µMNEDD8, 4 µMUBE2M, and 0.2 μMNAE in 50 mMTris-HCl pH 8 with 0.15 mMATP, 1.5 mMMgCl2 and 20% glycerol.
Reactions were performed for 2 min at 30°C and quenched by the addition of SDS loading buffer. Samples were resolved by SDS-PAGE and processed for
immunoblotting with the indicated antibodies. Cul3 is readily neddylated in the absence of CAND1 as seen from the ∼10 kDa band shift in lane 2 (asterisk).
Addition of CAND1 inhibits the neddylation reactions, and inhibition is relieved upon the addition of Cul3 substrate adaptor KLHL3.
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Fig. 3. Tissue-specific expression and subcellular localization of DCNLs. (A) DCNLs have unique tissue expression profiles and upregulation in cancer cell
lines. Western blot analysis of mouse tissue lysates and cancer cell lysates (30 μg each) and where indicated recombinant protein (50 ng). DCNL1 is widely
expressed in all tissue samples as well as cancer cell lines. DCNL2 expression is more restricted with highest expression in the brain, liver and kidneys. At
least one of the three isoforms of DCNL4 is expressed in most tissue, albeit at varying levels. DCNL3 expression is restricted to testis and brain with weak
expression in cancer cell lines. DCNL5 has low expression in testis, skin, thymus and spleen but is drastically upregulated in the three cancer lines. (B) Subcellular
localization of DCNLs is independent of cullin binding. U2OS cells expressing N-terminally FLAG tagged DCNL1–5 were analysed by indirect
immunofluorescence with an anti-FLAG antibody, rhodamine-conjugated Phalloidin (actin) and DAPI staining (scale bars: 10 µm). DCNL1 and DCNL2 are
localized throughout the cell in both the cytoplasm and nucleus. DCNL3 is located throughout the cell, but also at the plasma membrane. DCNL4 and DCNL5 are
restricted to the nucleus. Mutation of any of the DCNLs DAD patch domains does not cause a change in subcellular localization, suggesting DCNLs
localization is independent of cullin binding and instead determined by their unique N-terminal domain. (C) Diagram of each DCNL family member depicting their
conserved C-terminal PONY domain and specific N-terminal domain. Depicted onDCNL3 is amyristoylation site and depicted on DCNL5 is a nuclear localization
sequence (NLS). (D) Immunofluorescence analysis of U2OS cells stably expressing either GFP–DCNL5 WT or GFP–DCNL5 with mutations in the NLS
(scale bar: 10 µm). Mutation of the NLS sequence results in a delocalization of some DCNL5 into the cytoplasm.
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and kidney (Fig. 3A). DCNL4 was predominantly expressed as the
34 kDa isoform, except in testis, where the smaller 29 kDa isoform
was predominant, and in brain, where the 38 kDa and the 29 kDa
isoforms were expressed to approximately equal levels (Fig. 3A).
DCNL5 was only detectable at low levels in testis, skin and immune
tissues (thymus, spleen and lymph nodes), with the highest
expression in thymus and testis, suggesting that DCNL5 has
unique functions in these cells (Fig. 3A; Fig. S3).
DCNL1 is the evolutionarily oldest DCN isoform and most
closely related to the single homologs found in lower organisms,
and it might therefore also function as the main DCNL for cullin
complexes in mammalian cells (Kurz et al., 2005). However,
DCNL1 cannot be solely responsible for the neddylation of all
cullins, as DCNL1 knockout mice are viable, which would not be
expected if all cullins were affected by the deletion of DCNL1
(Huang et al., 2011). Thus, the other DCNLs probably regulate the
activity of certain subpopulations of CRL complexes. The restricted
expression pattern of most DCNLs suggests that these functions
could be tissue-specific. However, as no knockout animals for any
of the other DCNLs exist, we decided to investigate the potential
specificities in tissue culture cells, bearing in mind that some of the
specific effects might be masked because of the strong expression of
most DCNLs in this experimental system.
Previous work using recombinant proteins and in vitro assays
demonstrated that all recombinant DCNLs bind all cullins with only
slightly different affinities and can promote their neddylation in vitro
(Monda et al., 2013). Our immunoprecipitation analysis is less
sensitive, and it is difficult to comment on the relative affinities in cells
using our methodology. However, we do find that most DCNLs bind
to all cullins in our analysis with the exception ofDCNL4,which does
not interact with Cul4A or Cul4B. Furthermore, all human DCNLs
can rescue the neddylation defect of yeast DCN1 knockout cells when
overexpressed (Meyer-Schaller et al., 2009), demonstrating that they
are all capable of neddylating cullins, which we could confirm with
our in vitro reconstitution of neddylation. We thus concluded that it is
likely that distinct subcellular localization or binding partners, rather
than different affinities for different cullin subtypes, would mediate
any specificity in the system.
To investigate potential differences in subcellular localization, we
utilized stably expressing FLAG–DCNL U2OS cell lines to
determine their localization by indirect immunofluorescence with
an anti-FLAG antibody. This revealed that although there is some
overlap in their localization, DCNLs do have unique localization
patterns (Fig. 3B). We found that DCNL1 and DCNL2 localize to
both the nucleus and the cytoplasm of cells as previously described
(Huang et al., 2011) (Fig. 3B). DCNL3 was present at the plasma
membrane, in the cytoplasm and nucleus (Ma et al., 2008; Meyer-
Schaller et al., 2009) (Fig. 3B), whereas both DCNL4 and DCNL5
were almost exclusively nuclear (Fig. 3B). As both DCNL1 and
DCNL3 subcellular localization is governed by their respective N-
termini, we reasoned that this might also be the case for DCNL4 and
DCNL5 (Wu et al., 2011). Indeed, both their N-termini harbor a
putative nuclear localization signal (NLS) (Bommelje et al., 2014)
and its mutation in DCNL5 led to a diffusion of the protein into the
cytoplasm (Fig. 3C,D). This mutant form of DCNL5 is, however, not
entirely excluded from the nucleus, as it is small enough to passively
diffuse through the nuclear pore (27.5 kDa) (Fig. 3D). Interestingly,
mutation of the DAD patch motif, which disrupts cullin binding,
does not change the localization of any DCNL, which demonstrates
that the subcellular localization of DCNLs is independent of the
interaction with cullins, and must bemediated by other determinants,
possibly their unique N-termini (Fig. 3C).
DCNLs do not display a strong cullin preference in cells
The interaction data suggests that in tissue culture cells all DCNLs
probably contribute to the neddylation of all cullins. To examine if
this was the case and to determine the relative contribution of each
DCNL to the overall steady-state neddylation level of Cul1, 2, 3, 4A,
4B and 5, we downregulated the expression of each DCNL by siRNA
and determined the changes in cullin neddylation by western blot
(Fig. 4A). As expected from our interaction data, downregulation of
single DCNLs did not drastically affect the overall cullin neddylation
levels, indicating that there is strong functional overlap between the
different DCNL homologs in tissue culture cells (Fig. 4A). However,
downregulation of some DCNLs affected some cullins more strongly
than others. For example, although downregulation of DCNL1
seemed to slightly affect the neddylation of all cullins, it had a most
prominent effect on Cul1 and Cul4A (Fig. 4A). This is similar to the
downregulation of DCNL5, which also affected Cul1 and Cul4A
(Fig. 4A). DCNL4 downregulation, by contrast, only slightly affected
the neddylation of Cul5 and Cul4B (Fig. 4A). Curiously,
downregulation of DCNL3 increased neddylation of Cul1, Cul3,
Cul4A and Cul4B (Fig. 4A), which suggests that DCNL3 might in
some instances inhibit cullin neddylation instead of promoting it
(Huang et al., 2014). Thus, at least in tissue culture cells, there is not a
single DCNL that is predominantly required for the neddylation of
any one cullin. Instead, the different DCNLs appear to contribute to
the overall neddylation pattern of most cullins.
However, given that siRNA downregulation might not remove all
protein from the cell, it was possible that any remaining protein was
sufficient to neddylate cullins and to thus mask more specific
requirements. In order to explore this possibility, we generated
knockout cell lines forDCNL1 andDCNL5 using the CRISPR/Cas9
method in U2OS cells (Ran et al., 2013; Munoz et al., 2014; Mali
et al., 2013; Heigwer et al., 2014) (Fig. 4B). Similar to siRNA-
mediated downregulation, a complete knockout of DCNL1 or
DCNL5 did not entirely abolish the neddylation of any one cullin
(Fig. 4C). However, it did more significantly affect the neddylation
of most cullins compared with siRNA-mediated knockdown of
DCNL1 and DCNL5 (Fig. 4A,C). Knockout of DCNL1 reduced the
neddylation of Cul1, Cul3, Cul4A andCul5, but left Cul2 andCul4B
unaffected (Fig. 4C). DCNL5 knockout, by contrast, affected all
cullins tested (Fig. 4E). However, neither knockout affected the
neddylation of any cullin to more than∼25% of the parental cell line
(Fig. 4C). The effects we see on the neddylation of different cullins
does not directly correlatewith the reported affinities inMonda et al.
(2013) or our slight differences in interaction between cullins and
DCNLs as analysed by mass spectrometry. However, given that the
different affinities are ultimately very similar, it is not surprising that
other factors govern which cullin is predominantly affected by a
specific DCNL. Overall these results again highlight the fact that
different DCNLs contribute to the steady-state neddylation level of
many cullins, but they also suggest that distinct DCNLs are
responsible for the neddylation of a given subpopulation of a cullin,
because if they were entirely redundant, we would not expect to
detect any effects on cullin neddylation upon loss of a single DCNL.
Thus, DCNLs might have non-redundant functions with respect to
certain cullin subpopulations and these could be mediated by
differences in their subcellular localization.
DCNL1 and DCNL5 independently contribute to cullin 4A
neddylation, but only DCNL5 affects the DNA damage
response
To test whether this was the case, we more closely examined the
effect of DCNL1 and DCNL5 knockout on Cul4A, as both
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knockout cell lines showed a reduction of Cul4A neddylation
(Fig. 4C). This reduction, albeit mild, could be rescued by re-
expressing wild-type DCNL1 or DCNL5 but not DAD patch mutant
forms (Fig. 5A–D). Additional siRNA-mediated knockdown of
DCNL5 in the DCNL1 knockout cell line, or DCNL1 in the DCNL5
knockout cell line, further reduced Cul4A neddylation levels, which
suggested that DCNL5 and DCNL1 act independently from each
other to neddylate distinct Cul4A pools (Fig. 5E,F). However, it is
Fig. 4. See next page for legend.
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unclear which Cul4A pools are affected by DCNL1 or DCNL5 and
whether they have distinct functions. Cul4A has been implicated in
processes both in the cytoplasm (Kuang et al., 2013) and in the
nucleus (Chen et al., 2001; Nag et al., 2001; Shiyanov et al., 1999),
where Cul4A is involved in DNA replication and DNA repair
(Zhong et al., 2003; Higa et al., 2003; Hu et al., 2004). CRL4
complexes (comprising Cul4A, RBX1 and DDB1) are particularly
important for the management of UV-induced DNA lesions and
cells that lack the CRL4 substrate receptor DDB2 are very sensitive
to UV light (Chu and Chang, 1988; Scrima et al., 2008; van Cuijk
et al., 2015).
Given that DCNL1 and DCNL5 affect Cul4A neddylation, we
asked if they are essential for CRL4-dependent DNA damage repair.
To test this, we determined sensitivity of the knockout cell lines in
clonogenic survival assays following UV exposure. We found that
only DCNL5 knockout cells showed sensitivity to UV light
(Fig. 6A) that could be rescued by re-expressing GFP-tagged
DCNL5 (Fig. 6A). Thus, DCNL5 knockout sensitizes cells to UV
damage, which represents a function that is not shared with DCNL1.
To determine if DCNL5 is involved directly in the DNA damage
response, we asked whether DCNL5, like Cul4A, localizes to sites
of DNA damage. We sensitized cells with 5-bromo-2′-deoxyuridine
(BrdU) or mono-psoralen and subsequently micro-irradiated the
nucleus with a 355-nm UV-A laser to induce DNA lesions along a
defined track (Lachaud et al., 2014; Perez-Oliva et al., 2015). As
previously reported, Cul4A localizes to this type of DNA damage
(Fig. 6B) (Meir et al., 2015) and, importantly, endogenous DCNL5
does as well (Fig. 6B). An exogenously expressed GFP–DCNL5
construct was also recruited to the track of DNA damage
independently of the interaction with cullins, as the GFP–
DCNL5-DAD patch mutant was similarly recruited (Fig. 6C). In
DCNL5-DAD patch mutant cells, Cul4A was also still recruited to
sites of damage, demonstrating that the ability of DCNL5 to bind to
cullins is not required for the localization of Cul4A (Fig. S4A).
Thus, we concluded that the sensitivity of DCNL5 knockout cells to
UV induced damage is most likely a direct consequence of its role in
neddylating Cul4A at sites of damage.
Because of the lack of UV sensitivity of DCNL1 knockout cells,
we expected that DCNL5 would be the only DCNL recruited to
damage sites. To confirm this assumption, we also tested whether
any of the other DCNLs localized to sites of damage. Contrary to
our expectations, we found that all DCNLs were strongly recruited
(Fig. 6D), with the exception of DCNL3 that was barely detectable
at damage sites. It thus appears that most DCNLs might have a role
at sites of DNA damage. The significance of this finding, however,
is unclear at the moment. There might be redundancy in the system,
but given that the DCNL5-knockout cells show sensitivity to UV-
induced DNA damage, whereas the DCNL1-knockouts do not, it is
likely that at least the role of DCNL5 at damage sites is to some
degree non-redundant.
DCNL3 is the only DCNL that does not seem to readily go to sites
of damage. However, even DCNL3 might regulate the DNA
damage response, as siRNA to DCNL3 leads to increased Cul4A
neddylation. Whether this effect is indirect or direct, by for example
DCNL3-dependent sequestration of Cul4A in the cytoplasm, is
unclear. However, as overexpression of DCNL3 does not lead to a
defect in the recruitment of Cul4A to sites of DNA damage or to
decreased neddylation of Cul4A (Fig. 6E; Fig. S4B), it is unlikely
that the effect is simply mediated by means of sequestration.
Furthermore, when we replaced the N-terminus of DCNL3 with that
of DCNL5, DCNL3 was equally well recruited to sites of damage as
other DCNLs; thus, any unique function of DCNL3 is mediated by
its N-terminus (Fig. 6E), which based on our results, is probably
true for the other DCNLs as well.
DISCUSSION
Cullin RING ligases are the largest class of ubiquitin E3s and
because of their modularity are able to form complexes that target
hundreds of substrates for ubiquitylation. This class of E3 ligases
share a common regulatory mechanism involving neddylation of
the central cullin subunit, which is mediated in part by the
DCNLs. It has long been puzzling why higher organisms contain
multiple DCNLs that differ in their N-terminal domains. The most
obvious explanation would be that they target different cullin
subtypes, allowing the cell to regulate cullins independently.
However, this is not the case, as DCNLs show no obvious cullin
preference in cells or in vitro, even though small differences in
affinities exist. The effects we see on the neddylation of different
cullins after DCNL downregulation does, however, not directly
correlate with the reported differences in affinities (Monda et al.,
2013) or our observed slight differences in interaction between
cullins and DCNLs as analysed by mass spectrometry. Other
factors thus probably govern which cullin is affected by a specific
DCNL. For instance, given that we found that most DCNLs are in
complex with inactive cullin–RING cores and CAND1, it is hard
to predict which DCNL interacts with the more ‘active’
subpopulation of any given cullin. For example, although
DCNL1 might immunoprecipitate overall more Cul5 than
DCNL5, it is possible that most DCNL1-bound Cul5 is inactive
and also bound to CAND1, whereas the DCNL5-bound Cul5 is
more readily engaged with active complexes. If so, then
inactivation of DCNL5 would affect neddylation of Cul5 more
than inactivation of DCNL1, even though more DCNL1 co-
precipitates with Cul5.
So what are the functions of the different DCNLs and how
are they regulated? Importantly, we now show that in cultured
cells the DCNL isoforms display different subcellular
Fig. 4. Effects of DCNL downregulation on cullin neddylation.
(A) Knockdown of DCNLs by siRNA has only mild effects on the overall level of
individual cullin neddylation. U2OS cells were treated with specific DCNL
siRNAs or control siRNA for 72 h, and where indicated the neddylation inhibitor
MLN4924 was added for 3 h at 3 μM. Following treatment, cells where
harvested and processed for western blotting for the cullin family members to
assess the fraction of cullin that was modified by NEDD8. Knockdown of
DCNL1 reduces the amount of neddylated Cul1, 4A and 5, whereas
knockdown of DCNL2 or DCNL4 had no effect on neddylation levels.
Knockdown of DCNL3 increased Cul1 and Cul4A neddylation and DCNL5
knockdown reducedCul4A andCul5 neddylation levels. Adjacent graphs show
the means±s.e.m. of quantified percentage of neddylated cullins. Statistical
significancewas determined by one-way ANOVAwith Newman–Keuls multiple
comparison test. *P≤0.05; n≥3. (B) Schematic of DCNL1 and DCNL5
sequences targeted by CRISPR/Cas9-mediated gene knockout with
Protospacer adjacent motif (PAM) indicated (purple) and Cas9 cleavage site
marked with an arrow. Depicted below each WT sequence are the mutations
(in red) as determined by DNA sequencing. (C) Reduced cullin neddylation in
U2OS knockout cells (individual clones) for DCNL1 and DCNL5 generated by
CRISPR/Cas9. Whole cell lysates were prepared from WT, DCNL1 KO and
DCNL5 KO and processed for SDS-PAGE and immunoblotting for cullin family
members to assess the changes in the fraction of neddylated cullins upon loss
of DCNL1 or DCNL5. DCNL1 knockout has the strongest effect on Cul4A
neddylation and caused mild reduction of Cul3 and Cul5 neddylation. DCNL5
knockout caused reduced neddylation of all cullins tested with the greatest
effect on Cul4A, Cul4B and Cul2. Adjacent graphs show the means±s.e.m. of
quantified percentage of neddylated cullins. Statistical significance was
determined by one-way ANOVAwith Newman–Keulsmultiple comparison test.
*P≤0.05, **P≤0.01, ***P≤0.001; n≥3. Asterisks denote the slower migrating
neddylated form of the two cullin-reactive bands.
1448
RESEARCH ARTICLE Journal of Cell Science (2016) 129, 1441-1454 doi:10.1242/jcs.181784
Jo
u
rn
al
o
f
Ce
ll
Sc
ie
n
ce
localization patterns. It is thus feasible that through regulation
of different DCNL subtypes, the cell specifically regulates
cullin–RING ligase activity in different places in the cell. Our
data further suggests that compartmentalization is mediated by
the N-termini, which probably have regulatory functions
independent of the actual NEDD8 E3 activity of DCNLs.
Furthermore, studies on DCNL3 have shown that its N-terminus
is important for localization to the plasma membrane, where it
neddylates Cul3 (Meyer-Schaller et al., 2009). We also find
DCNL3 at the plasma membrane, but curiously, downregulation
of DCNL3 by siRNA increases the neddylation of many cullins.
Thus, at least in some instances, DCNL3 appears to inhibit
cullin neddylation (Huang et al., 2014). The mechanism by
which this occurs, however, remains elusive, but we can
speculate that DCNL3 sequesters cullins away from the
neddylation machinery.
Fig. 5. DCNL1 and DCNL5 independently contribute to Cul4A neddylation. (A) Cul4A neddylation partly depends on DCNL1 expression. Western blot
analysis of lysates from U2OS cell lines stably expressing siRNA-resistant transgenes for FLAG–empty, FLAG–DCNL1 (WT), or FLAG–DCNL1 (DAD mutant).
Cells were treated with control or DCNL1 siRNA for 72 h. Transgene expression was induced by doxycycline (0.5 ng/ml) for 24 h.Where indicated, MLN4924 was
added for 3 h at 3 μM. Cell lysates were resolved by SDS-PAGE and immunoblotted with anti-Cul4A antibody to assess the fraction of neddylated cullin. siRNA
depletion of DCNL1 reduces Cul4A neddylation, which can be rescued by re-expression of DCNL1 (WT) but not cullin-binding-deficient DAD mutant. (B) Cul4A
neddylation partly depends on DCNL5. Whole cell lysates were prepared as in A but cell lines stably expressed FLAG–empty, FLAG–DCNL5 (WT) or FLAG–
DCNL5 (DAD mutant) and siRNAwas targeted against DCNL5 or control. siRNA-mediated depletion of DCNL5 reduces the fraction of Cul4A that is neddylated.
Upon re-expression of WT DCNL5, Cul4A neddylation is rescued to wild-type levels. The cullin-binding-deficient DAD patch mutant of DCNL5 fails to rescue
Cul4A neddylation, suggesting DCNL5 directly interacts with Cul4A to promote neddylation. (C) Cul4A neddylation in DCNL1-KO cells directly depends on
DCNL1 expression. Cul4A neddylation was assessed by western blot analysis of lysates from U2OS DCNL1 KO cell lines that stably express Flp-In-generated
GFP, GFP–DCNL1 (WT) or GFP–DCNL1 (DADmutant). Similar to the Cul4A neddylation reduction by siRNA depletion of DCNL1, knockout of DCNL1 can only
be rescued by re-expression ofWTDCNL1, but not DAD patchmutant DCNL1. (D) Cul4A neddylation in DCNL5-KO cells directly depends onDCNL5 expression.
Same as in C except the U2OS knockout cell line was DCNL5 and rescue lines were Flp-In for GFP, GFP–DCNL5 (WT) or GFP–DCNL5 (DAD mutant). Cul4A
neddylation is rescued by re-expression ofWT but not DAD patchmutant DCNL5. (E) DCNL5 depletion has an additive effect onCul4A neddylation in DCNL1 KO-
cells. The fraction of neddylated Cul4Awas determined by western blot analysis of cell lysates fromWTor DCNL1 KO treated with control siRNA or siRNA against
DCNL5. Additional depletion of DCNL5 in DCNL1-KO cells further reduces the amount of neddylated Cul4A. This additive effect of DCNL5 depletion suggests
there are separate pools of Cul4A that are independently neddylated by DCNL1 or DCNL5. (F) DCNL1 depletion has an additive effect on Cul4A neddylation in
DCNL5-KO cells. Same as in E, but the cell lines wereWTor DCNL5 KO and treatment was with control siRNA or siRNA against DCNL1. The additional depletion
of DCNL1 in DCNL5-KO cells mirrors the result in E and further supports that model that separate pools of Cul4A are independently regulated by DCNL1 or
DCNL5. All graphs plot the means±s.e.m. of quantified percentage of neddylated Cul4A. Statistical significance was determined by one-way ANOVA with
Newman–Keuls multiple comparison test. **P≤0.01, ***P≤0.001; n≥3. Asterisks denote the slower migrating neddylated form of the two cullin-reactive bands.
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Fig. 6. See next page for legend.
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One surprising result was that all DCNLs strongly interact with
CAND1, which was counterintuitive, as CAND1 only binds non-
neddylated cullins (Liu et al., 2002; Zheng et al., 2002). However,
our data unequivocally demonstrate that DCNLs and cullin–RBX1
form heterotrimeric complexes with CAND1. CAND1 binding
prevents cullin neddylation by DCNLs, which is counteracted by
substrate adaptors. The presence of a NEDD8 E3 in a non-
neddylatable CRL might be important to allow a rapid activation
when the need arises. These complexes thus probably represent
inactive cullin reservoirs primed for activation by neddylation.
Given that we find that DCNLs only interact with non-neddylated
cullins, it is likely that DCNLs dissociate upon neddylation and that
in the cell most DCNLs are in fact present in inactive CRL
complexes.
Our data also strongly suggest that all DCNLs contribute to the
neddylation of most, if not all, cullins and it is thus likely that any
cullin can be targeted by any DCNL as long as it is present in the
same compartment. The system is further complicated by the fact
that the DCNLs show some overlap in localization. For example,
DCNL1 and DCNL2 are both present in the nucleus and cytoplasm,
DCNL3 localizes to the plasma membrane, whereas DCNL4 and
DCNL5 are exclusively nuclear. So theoretically, all DCNLs should
be able to neddylate nuclear cullins. However, there are still
functional differences, as our data suggest that DCNL5 serves a
unique role in the DNA damage response even though other DCNLs
also localize to sites of DNA damage. Future experiments will be
required to determine their role, but given the lack of sensitivity of
DCNL1 knockout cells to UV light, it is possible that DCNL1 acts
redundantly with one or all of the other DCNLs at damage sites,
whereas DCNL5 retained a unique function. Similar to our findings,
it was recently shown that the NEDD8 E2s UBE2M and UBE2F
both localize to laser stripe, but only UBE2M depletion made cells
sensitive to DNA damage (Brown et al., 2015).
In general, all our data is consistent with a model whereby,
depending on its localization, a cullin becomes activated by a
different DCNL. As a consequence, the overall neddylation of the
cellular pool of a cullin would not be strongly affected by depletion
of single DCNLs, which is what we observed. Furthermore,
depletion of two DCNLs has additive effects on cullin neddylation,
which further supports the idea that different DCNLs are
neddylating different subpopulations of the same cullin. This
‘specialization’ might allow the cell to regulate the activity of
distinct cullin pools without affecting all CRLs built around one
cullin subtype.
Furthermore, all DCNLs are widely expressed in tissue culture
cells, which is very different from the organismal level where tissue-
specific expression is apparent. This ectopic expression of most
DCNLs might thus contribute to some degree to the redundancy of
the system in tissue culture. Moreover, given that at least DCNL1
and DCNL5 are oncogenic, it is crucially important for the cell to
regulate the activity of DCNL E3s. Although speculative, it is
possible that strong DCNL1 and/or DCNL5 expression interferes
with regulatory mechanisms on other DCNLs, overriding their
regulation and facilitating the development of cancer.
Given these results, it will become important in the future to study
these enzymes in defined primary cells and relevant physiological
contexts to understand their specific functions. This will especially
be important for the DCNLs that show tissue-specific expression.
These NEDD8 E3s will probably have unique functions in these
tissues that are impossible to study in cancer cell lines. To fully
understand the specificity, regulation and function of all DCNLs
will thus require a closer look at tissue-specific roles and the
generation of animal models that carry deletions or mutations of
single DCNLs.
MATERIALS AND METHODS
Antibodies
Immunoblotting: anti-FLAG M2 (F3165, Sigma, 1/2000); anti-DCNL1
(Clone 3D7, Sigma-Aldrich, 1/1000); anti-GAPDH (Cell Signalling Clone
14c10 cat. no. 2118, 1/2000); anti-Actin (MAB1501, Millipore, 1/1000);
anti-cullin1 (718700, Life Technologies, 1/1000); anti-cullin2 (700179,
Life Technologies, 1/5000); anti-ACADVL (PA5-29959, Thermo
Scientific, 1/1000); mouse anti-GFP (ab184519, Abcam, 1/2000). Sheep
polyclonals were raised against full-length KLHL3, the N-terminus of
DCNL3, 4 and 5, Cul4A and 4B, and against the C-terminus of Cul3 and
Cul5, and used at 1 µg/ml.
Immunofluorescence: mouse anti-FLAG M2 (F3165, Sigma, 1/1000);
chicken anti-GFP (ab13970, Abcam, 1/1000); sheep anti-DCNL5 (our own
1/200); sheep anti-cullin4A (our own, 1/100); anti-γ-H2Ax (05-636,
Millipore, 1/1000), and secondary antibodies conjugated to Alexa-Fluor-
488 or -594 from Life Technologies (1/1000).
Cell culture
U2OS and HEK-293 were grown in GIBCO DMEM with 10% GIBCO
FBS, L-glutamine, 100 units/ml penicillin and 100 µg/ml streptomycin (Life
Technologies).
HEK-293 and U2OS cells stably expressing tagged DCNLs were
generated using the Flp-In T-Rex system (Life Technologies). Expression
was induced with 1 µg/ml tetracycline (Sigma-Aldrich) overnight. All cell
lines used were originally obtained from ATCC and regularly tested for
contamination.
Cell extracts, immunoprecipitation and immunoblot analyses
Whole-cell extracts were prepared by lysis in 50 mM Tris-HCl pH 7.4,
150 mMNaCl, 1 mMEDTA, 1 mMEGTA, 50 mM sodium fluoride, 5 mM
sodium pyrophosphate, 10 mM sodium β-glycerol-1-phosphate, 1 mM
sodium orthovanadate, 0.27 M sucrose, 1% Triton X-100, 15 mM
Fig. 6. DCNL5 but not DCNL1 is involved in the DNA damage response.
(A) Clonogenic survival analysis of U2OS cells (WT, DCNL1 KO, DCNL5 KO
and DCNL5 KO re-expressing WT DCNL5) carried out after UV exposure. 500
cells/well were plated in six-well plates and 24 h later exposed to indicated
amounts of UV radiation. Cells were allowed to grow for 14 days and colony
formation was assessed by Crystal Violet staining. Cells able to form colonies
are interpreted as having repaired the UV-induced damage. DCNL5-KO cells
have an impaired ability to form colonies after UVexposure, suggesting defects
in DNA repair mechanisms. DCNL1-KO cells are not sensitive to DNAdamage.
Each datapoint is the mean±s.e.m. of three experiments undertaken in at least
three replicates. (B) DCNL5 is recruited to sites of DNA damage.
Immunofluorescence of U2OS cells treated with BrdU (10 µM, 24 h; upper
panels) or mono-psoralen (25 µM, 3 h; lower panels). Cells were fixed
5–10 min after laser micro-irradiation and stained for endogenous DCNL5 or
Cul4A, phosphorylated γ-H2AX and DAPI. The histone variant γ-H2AX, a
marker of DNA damage, serves as a positive control. DCNL5 and Cul4A are
also recruited to the site of DNA damage. (C) DCNL5 is recruited to DNA
damage sites independently of cullin binding. Live-cell analysis of U2OS cells
stably expressing GFP, GFP–DCNL5 (WT) or GFP–DCNL5 (DAD mutant).
Cells were BrdU-treated (10 µM, 24 h) and images captured at indicated times
after micro-irradiation with a 355 nm UV laser. Both WT DCNL5 and mutant
DCNL5 are recruited to DNA damage sites. (D) DCNL recruitment to sites of
DNA damage. U2OS cells were transfected with N-terminally GFP-tagged
DCNLs. 24 h after transfection, cells were treated as in C. All slides were
treated identically and images were taken with the same microscope with
identical settings. All DCNLs are readily recruited to sites of DNA damage with
the exception of DCNL3, which displays only very weak recruitment. (E) U2OS
cells transiently transfected with FLAG–DCNL3 or chimeric FLAG–DCNL3
where the N-terminal domain (aa 1–85) was replaced with the N-terminus
domain of DCNL5 (aa 1–46). Cells were treated as in C and D. Replacement of
the N-terminus readily targets DCNL3 to sites of DNA damage. Scale bars:
10 µm.
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iodoacetamide, 3 mM 1,10 phenanthroline (Sigma-Aldrich) and complete
phosphatase inhibitor PhosSTOP (Roche). FLAG-tagged proteins were
isolated by immunoprecipitation from 2–3 mg of lysate using 10 µl FLAG
(M2)-magnetic beads (Sigma) for 2 h at 4°C.
Immunoprecipitations were washed in lysis buffer before elution by LDS
sample buffer. To detect protein in cell lysates, samples were separated by
SDS-PAGE, transferred onto nitrocellulose or PVDF and visualized by
immunoblotting or ECL (Millipore).
RNA interference
Transfection was carried out using Lipofectamine as described previously
(Hjerpe et al., 2012a,b). SMARTpool siRNA oligos from GE Dharmacon
(Little Chalfont, UK) were used, siRNA against the DCNL1 3′UTR
(5′-UACAUAGUCUGUACAAUAA-3′) was synthesized by Eurofins
(Ebersberg, Germany).
Cas9/CRISPR knock out cell lines
The guideRNAvectors for exon 1 in DCNL1 and DCNL5were generated by
mutagenesis PCR of pEsgRNA (Munoz et al., 2014). The target sequences
for DCNL1 and DCNL5 were respectively CCAACATGGTGAGGCAC-
TGCGGC and GCAGCAGTAGCGGAAGACGGAGG (+ strand 5′–3′).
The constructs were transfected using GeneJuice (Millipore) into U2OS
stably expressing FLAG–Cas9 under tetracycline-inducible promoter and
single-cell cloned.
Immunofluorescence
Cells were fixed (10 min, 4% paraformaldehyde), permeabilized (5 min;
0.5% NP40 in PBS; room temperature); blocked overnight [4°C; 3%
IgG-free BSA (Jackson ImmunoResearch) and 0.02% Tween in PBS].
Cells were stained with anti-FLAG (1:2000) followed by anti-mouse
Alexa Fluor 488 (1:1000), Rhodamine-conjugated phalloidin
(Life Technologies, 1/4000) and DAPI (Sigma-Aldrich; 1 µg/ml),
and mounted using Mowiol 4-88 (Polysciences Inc., Warrington,
PA, USA).
Protein expression and purification
The following purified proteins were previously described in Kelsall et al.,
(2013): Nedd8 and the APPBP1–UBA3 heterodimer (Ohta et al., 2013);
DAC–TEV–Cul3–RBX1 and KLHL3 (Schumacher et al., 2015); GST–
CAND1. DCNL1, 2, 3, 4 and 5 were expressed with His6 tags in BL21 and
purified by Ni2+–Sepharose (GE Healthcare). GST–DCNL1 and GST–
DCNL2 were purified by GSH–Sepharose (GE Healthcare).
In vitro binding assays
3.6 µg His6–DCNLwas bound to magnetic Ni-NTA beads (Sigma) at 4°C in
50 mM Tris-HCl pH 8.0 and 20% glycerol. Cul3–Rbx1–CAND1
complexes were formed by incubating 9.2 µg Cul3–Rbx1 with 12.4 µg
CAND1 at 4°C. His6–DCNL beads were incubated with Cul3–Rbx1–
CAND1 for 20 min at 4°C, then washed three times with binding buffer
containing 10 mM imidazole (Sigma). Complexes were eluted with
300 mM imidazole and analysed by SDS-PAGE and Coomassie staining.
Neddylation assays
Cul3–Rbx1 (1 µM) and 1 µM DCNL were incubated with 34 µM NEDD8,
4 µM UBE2M and 0.2 µM NAE in reaction buffer (50 mM Tris-HCl
pH 8.0, 0.15 mM ATP, 1.5 mM MgCl2, 20% Glycerol) for 2 min at 30°C,
then quenched with LDS buffer. In some reactions 1 µM CAND1 or 1 µM
CAND1 plus 10 µM KLHL3 were included.
Laser irradiation and confocal microscopy
U2OS cells were seeded in 35-mm glass-bottom dishes at 1×106 cells per
dish and incubated with mono-psoralen at 25 µM for 2 h or with BrdU at
10 µM for 24 h. A PALMMicroBeam system (Carl Zeiss AG, Oberkochen,
Germany) was used to irradiate with the 355 nm UV laser at 20–25% for
cells treated with mono-psoralen and BrdU. Indirect immunofluorescence
was performed as described previously (Lachaud et al., 2014). A minimum
of 100 cells were irradiated per replicate.
Induction of DNA damage and colonogenic cell survival assays
500 cells/well were plated in six replicates onto 6-well plates. Media from
cells was aspirated 24 h after plating and cells were exposed to UV using a
Spectrolinker XL-1500 UV cross-linker (Spectroline, Westbury, NY). Fresh
media was added and colonies were grown for 14 days. Media was aspirated
and plates stained with Crystal Violet (Sigma). Colonies with >100 cells
were counted. For each condition, cell viability of untreated cells was
defined at 100%.
Mass spectrometry analysis
After immunoprecipitation and washings with lysis buffer and detergent-
free buffer (100 mM Tris HCl pH 8.5), FLAG-tagged proteins were eluted
with acetonitrile/formic acid 1% (ratio 1:1). The eluate was dried (Speedvac,
Thermo Scientific) and resupended in 300 µl buffer containing 1 M urea,
100 mM ammonium bicarbonate pH 8.0, 5 mM DTT (Sigma-Aldrich), and
0.01% RapiGest (Waters, Milford, MA). 5% of eluate was processed by
SDS-PAGE on 4–12% gradient gels and silver stained. The remainder was
alkylated in the dark for 60 min at 30°C in 15 mM chloroacetamide (Sigma-
Aldrich). Samples were digested overnight at 37°Cwith 3.75 µg/ml of mass-
spectrometry-grade Trypsin (Promega; Madison, WI). Samples were
acidified to pH 3 (trifluoroacetic acid; Sigma-Aldrich) and centrifuged at
17,000 g for 5 min to remove RapiGest. Supernatant was bound to c18
columns (Harvard Apparatus; Holliston, MA) washed with 0.1% TFA and
eluted with 60% acetonitrile and 0.1% TFA. Samples were run on a Thermo
Scientific Orbitrap Classic. RAW files were analysed with MaxQuant and
interaction heatmaps were generated in R (R-project).
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M. J., Cruz-Garcıá, A., Star, A., Shochot, L., Thomas, Y. et al. (2015). The
COP9 signalosome is vital for timely repair of DNA double-strand breaks. Nucleic
Acids Res. 43, 4517-4530.
Meyer-Schaller, N., Chou, Y.-C., Sumara, I., Martin, D. D. O., Kurz, T., Katheder,
N., Hofmann, K., Berthiaume, L. G., Sicheri, F. and Peter, M. (2009). The
human Dcn1-like protein DCNL3 promotes Cul3 neddylation at membranes. Proc.
Natl. Acad. Sci. USA 106, 12365-12370.
Monda, J. K., Scott, D. C., Miller, D. J., Lydeard, J., King, D., Harper, J. W.,
Bennett, E. J. and Schulman, B. A. (2013). Structural conservation of distinctive
N-terminal acetylation-dependent interactions across a family of mammalian
NEDD8 ligation enzymes. Structure 21, 42-53.
Munoz, I. M., Szyniarowski, P., Toth, R., Rouse, J. and Lachaud, C. (2014).
Improved genome editing in human cell lines using the CRISPR method. PLoS
ONE 9, e109752.
Nag, A., Bondar, T., Shiv, S. and Raychaudhuri, P. (2001). The xeroderma
pigmentosum group E gene product DDB2 is a specific target of cullin 4A in
mammalian cells. Mol. Cell. Biol. 21, 6738-6747.
Ohta, A., Schumacher, F.-R., Mehellou, Y., Johnson, C., Knebel, A., Macartney,
T. J., Wood, N. T., Alessi, D. R. and Kurz, T. (2013). The CUL3-KLHL3 E3 ligase
complex mutated in Gordon’s hypertension syndrome interacts with and
ubiquitylates WNK isoforms: disease-causing mutations in KLHL3 and WNK4
disrupt interaction. Biochem. J. 451, 111-122.
Perez-Oliva, A. B., Lachaud, C., Szyniarowski, P., Munoz, I., Macartney, T.,
Hickson, I., Rouse, J. and Alessi, D. R. (2015). USP45 deubiquitylase controls
ERCC1-XPF endonuclease-mediated DNA damage responses. EMBO J. 34,
326-343.
Petroski, M. D. and Deshaies, R. J. (2005). Function and regulation of cullin-RING
ubiquitin ligases. Nat. Rev. Mol. Cell Biol. 6, 9-20.
Pierce, N. W., Lee, J. E., Liu, X., Sweredoski, M. J., Graham, R. L., Larimore,
E. A., Rome, M., Zheng, N., Clurman, B. E., Hess, S. et al. (2013). Cand1
promotes assembly of new SCF complexes through dynamic exchange of F box
proteins. Cell 153, 206-215.
Pintard, L., Kurz, T., Glaser, S., Willis, J. H., Peter, M. and Bowerman, B. (2003).
Neddylation and Deneddylation of CUL-3 is required to target MEI-1/Katanin for
degradation at the meiosis-to-mitosis transition in C. elegans. Curr. Biol. 13,
911-921.
Rabut, G. and Peter, M. (2008). Function and regulation of protein neddylation.
‘Protein modifications: beyond the usual suspects’ review series. EMBO Rep. 9,
969-976.
Rabut, G., Le Dez, G., Verma, R., Makhnevych, T., Knebel, A., Kurz, T., Boone,
C., Deshaies, R. J. and Peter, M. (2011). The TFIIH subunit Tfb3 regulates cullin
neddylation. Mol. Cell 43, 488-495.
Ran, F. A., Hsu, P. D., Wright, J., Agarwala, V., Scott, D. A. and Zhang, F. (2013).
Genome engineering using the CRISPR-Cas9 system.Nat. Protoc. 8, 2281-2308.
Sarikas, A., Hartmann, T. and Pan, Z.-Q. (2011). The cullin protein family.Genome
Biol. 12, 220.
Sarkaria, I., O-charoenrat, P., Talbot, S. G., Reddy, P. G., Ngai, I., Maghami, E.,
Patel, K. N., Lee, B., Yonekawa, Y., Dudas, M. et al. (2006). Squamous cell
carcinoma related oncogene/DCUN1D1 is highly conserved and activated by
amplification in squamous cell carcinomas. Cancer Res. 66, 9437-9444.
Schumacher, F.-R., Siew, K., Zhang, J., Johnson, C., Wood, N., Cleary, S. E., Al
Maskari, R. S., Ferryman, J. T., Hardege, I., Yasmin et al. (2015).
Characterisation of the cullin-3 mutation that causes a severe form of familial
hypertension and hyperkalaemia. EMBO Mol. Med. 7, 1285-1306.
Scott, D. C., Monda, J. K., Grace, C. R. R., Duda, D. M., Kriwacki, R. W., Kurz, T.
and Schulman, B. A. (2010). A dual E3 mechanism for Rub1 ligation to Cdc53.
Mol. Cell 39, 784-796.
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